var data={"title":"Clinical use of saw palmetto","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clinical use of saw palmetto</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/contributors\" class=\"contributor contributor_credentials\">Robert B Saper, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/contributors\" class=\"contributor contributor_credentials\">Joann G Elmore, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/contributors\" class=\"contributor contributor_credentials\">Judith A Melin, MA, MD, FACP</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 16, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Extracts of the fruit from saw palmetto (<em>Serenoa repens</em>), the American dwarf palm tree (<a href=\"image.htm?imageKey=PC%2F57176\" class=\"graphic graphic_picture graphicRef57176 \">picture 1</a>), are commonly used to treat benign prostatic hypertrophy (BPH). The first evidence of saw palmetto use for urinary symptoms in men is from Egypt in the 15th century BC [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/1\" class=\"abstract_t\">1</a>]. Native Americans in Florida in the early 1700s utilized saw palmetto to treat prostate gland swelling and inflammation, testicular atrophy, and erectile dysfunction [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/2,3\" class=\"abstract_t\">2,3</a>].</p><p>In the 1870s, eclectic medical practitioners used the plant for urologic conditions. Saw palmetto berries were officially listed in the United States Pharmacopoeia in the first half of the 20<sup>th</sup> century [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/4\" class=\"abstract_t\">4</a>]. Saw palmetto use is common in Europe and somewhat less popular in the United States [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/5\" class=\"abstract_t\">5</a>].</p><p>A number of studies and meta-analyses have evaluated extracts of the saw palmetto berry for its safety and efficacy in the treatment of BPH; these are reviewed here. Detailed discussions of the treatment of BPH and the use of saw palmetto in the combination herbal product PC-SPES for the treatment of prostate cancer are discussed separately. (See <a href=\"topic.htm?path=alternative-endocrine-therapies-for-castration-resistant-prostate-cancer\" class=\"medical medical_review\">&quot;Alternative endocrine therapies for castration-resistant prostate cancer&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">MECHANISM OF ACTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The saw palmetto berry contains over 100 known compounds. The active ingredients in saw palmetto appear to be contained in the purified lipid soluble extract of the saw palmetto berry. This has been found to contain 85 to 95 percent fatty acids (predominantly lauric, caprylic, and caproic), long-chain alcohols, and sterols (including beta-sitosterol, stigmasterol, cycloartenol, lupeol, lupenone, and methylcycloartenol) [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/6\" class=\"abstract_t\">6</a>].</p><p>The exact mechanisms of action of saw palmetto are unknown [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/6\" class=\"abstract_t\">6</a>]. Proposed mechanisms include antiandrogenic effects [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/6,7\" class=\"abstract_t\">6,7</a>]; inhibition of type 1 and type 2 isoenzymes of 5-alpha-reductase [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/8-10\" class=\"abstract_t\">8-10</a>]; inhibition of growth factors such as the insulin-like growth factor-I [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/11\" class=\"abstract_t\">11</a>]; relaxation of lower urinary tract smooth muscle through antagonism of muscarinic receptors [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/12\" class=\"abstract_t\">12</a>]; antiinflammatory effects through inhibition of lipoxygenase, cyclooxygenase [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/13\" class=\"abstract_t\">13</a>], and leukotrienes [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/14\" class=\"abstract_t\">14</a>]; alteration of cholesterol metabolism; antiestrogenic effects; and a decrease in available sex hormone-binding globulin [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/6,15-18\" class=\"abstract_t\">6,15-18</a>].</p><p>In a double-blind study examining prostate tissue from 35 men treated with either saw palmetto or placebo for three months prior to prostatectomy for benign prostatic hypertrophy (BPH), a significant decrease in nuclear receptors for estrogen, progesterone, and androgen was seen in those men treated with saw palmetto [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/6\" class=\"abstract_t\">6</a>]. In another randomized, placebo-controlled trial of 40 men with BPH awaiting surgery, six months of saw palmetto treatment compared with placebo was associated with significant changes in the amount and organization of nuclear chromatin found at biopsy [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/19\" class=\"abstract_t\">19</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CLINICAL TRIALS/INDICATIONS</span></p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Benign prostatic hypertrophy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Saw palmetto is widely used for treatment of benign prostatic hypertrophy (BPH), but there are few data to support its efficacy. (See <a href=\"topic.htm?path=medical-treatment-of-benign-prostatic-hyperplasia\" class=\"medical medical_review\">&quot;Medical treatment of benign prostatic hyperplasia&quot;</a>.)</p><p>A systematic review published in 1998 of 18 mostly European randomized controlled trials (n = 2939) concluded there was promising evidence for efficacy of saw palmetto compared with placebo for decreasing nocturia, residual urine volume, and urinary tract symptom score [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/1\" class=\"abstract_t\">1</a>]. However, a 2012 systematic review of 32 randomized trials (n = 5666) comparing saw palmetto and placebo, including more recent trials and trials from the United States, did not find any differences in urinary symptom scores, measures of urinary flow, or prostate size [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/20\" class=\"abstract_t\">20</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Prostatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are no data supporting saw palmetto use in the treatment of chronic prostatitis [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/21\" class=\"abstract_t\">21</a>]. A one-year randomized controlled trial comparing saw palmetto with <a href=\"topic.htm?path=finasteride-drug-information\" class=\"drug drug_general\">finasteride</a> for chronic <span class=\"nowrap\">prostatitis/chronic</span> pelvic pain syndrome showed no improvement of the NIH Chronic Prostatitis Symptom Index score for the saw palmetto arm [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/22\" class=\"abstract_t\">22</a>]. (See <a href=\"topic.htm?path=chronic-prostatitis-and-chronic-pelvic-pain-syndrome\" class=\"medical medical_review\">&quot;Chronic prostatitis and chronic pelvic pain syndrome&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Prostate cancer</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In a random mail survey of men diagnosed with prostate cancer in Ontario, Canada, 11.8 percent reported use of saw palmetto [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/23\" class=\"abstract_t\">23</a>]. Although over half of those using saw palmetto reported using it to treat or cure their prostate cancer, there is no substantive evidence that saw palmetto influences the course of prostate cancer or changes prostate-specific antigen (PSA).</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">SAFETY</span></p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Adverse reactions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Only mild side effects, including headache, nausea, and dizziness, have been noted with the use of saw palmetto&nbsp;[<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/1\" class=\"abstract_t\">1</a>]. Adverse effects generally have been reported to be comparable to placebo. One study reported hypertension in 3.1 percent of patients receiving saw palmetto [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/24\" class=\"abstract_t\">24</a>]. There were no changes in laboratory values. Several studies have demonstrated that saw palmetto does not significantly affect the prostate-specific antigen (PSA) concentration [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/24-27\" class=\"abstract_t\">24-27</a>].</p><p>In a 2012 systematic review, there was no difference in the frequency of adverse events between saw palmetto and placebo (RR 0.94, 95% CI 0.27-3.19) [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/20\" class=\"abstract_t\">20</a>].</p><p>One case report of cholestatic hepatitis was reported with a combination product containing multiple ingredients including saw palmetto [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/28\" class=\"abstract_t\">28</a>]. Two cases of acute pancreatitis have also been linked to use of saw palmetto [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/29,30\" class=\"abstract_t\">29,30</a>]. One episode of intraoperative bleeding associated with an elevated bleeding time presumably related to saw palmetto has been reported [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/31\" class=\"abstract_t\">31</a>]. The authors speculate that this may have resulted from platelet dysfunction caused by cyclooxygenase inhibition.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Contraindications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Given the lack of safety data and its documented hormonal activity, use of saw palmetto is contraindicated in pregnancy and lactation [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/32\" class=\"abstract_t\">32</a>]. Saw palmetto should be discontinued two weeks prior to surgery [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/33\" class=\"abstract_t\">33</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">HERB-DRUG INTERACTIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The hormonal activity of saw palmetto could theoretically interfere with oral contraceptives and hormone therapy [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/32\" class=\"abstract_t\">32</a>]. Saw palmetto does not appear to interact significantly with the different cytochrome P450 isoforms [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/34,35\" class=\"abstract_t\">34,35</a>]. There is a theoretical risk of increased bleeding if combined with antiplatelet drugs or anticoagulants.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">DOSE</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common dosage of saw palmetto used in clinical trials is 160 mg twice daily of a dried lipophilic extract containing 80 to 90 percent fatty acids.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">BRAND</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Many different preparations of saw palmetto are available, often including a number of other agents such as <em>Pygeum africanum</em>, zinc, and additional compounds [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/6\" class=\"abstract_t\">6</a>]. One study analyzing six different brands of saw palmetto purchased from retail and specialty stores measured the actual saw palmetto content [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/36\" class=\"abstract_t\">36</a>]. Measured amounts of saw palmetto extract varied from 3 to 140 percent of the stated dosages on the labels. Three products contained less than 20 percent of the stated dosages. One brand showed statistical differences in measured dosage between lots. Similarly, a study of 14 brands of saw palmetto extract found significantly different amounts of free fatty acid content [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/37\" class=\"abstract_t\">37</a>]. An in vitro comparison of the inhibition of 5 alpha-reductase by different saw palmetto brands showed wide variation [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/38\" class=\"abstract_t\">38</a>].</p><p>New Good Manufacturing Practices for the dietary supplement industry have been established by the US Food and Drug Administration (FDA) and were phased in from 2008 to 2010 [<a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/39\" class=\"abstract_t\">39</a>]. Until it is clear these practices ensure quality, patients who choose to use saw palmetto can use products that have passed specified quality criteria by independent commercial laboratories. (See <a href=\"topic.htm?path=overview-of-herbal-medicine-and-dietary-supplements\" class=\"medical medical_review\">&quot;Overview of herbal medicine and dietary supplements&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Overall, large high-quality studies have not shown saw palmetto to be effective for the treatment of benign prostatic hypertrophy (BPH). We suggest not treating men with saw palmetto for BPH symptoms (<a href=\"grade.htm?i=1\" class=\"grade\">Grade 1A</a>). (See <a href=\"#H4\" class=\"local\">'Benign prostatic hypertrophy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Saw palmetto appears to be well-tolerated; serious side effects appear to be rare. (See <a href=\"#H7\" class=\"local\">'Safety'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/1\" class=\"nounderline abstract_t\">Wilt TJ, Ishani A, Stark G, et al. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 1998; 280:1604.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/2\" class=\"nounderline abstract_t\">Lowe FC, Ku JC. Phytotherapy in treatment of benign prostatic hyperplasia: a critical review. Urology 1996; 48:12.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/3\" class=\"nounderline abstract_t\">Bennett B, et al. Uses of saw palmetto (Serenoa repens, Arecaceae) in Florida. Econ Bot 1998; 52:381.</a></li><li class=\"breakAll\">DerMarderosian, A. Saw palmetto in the review of natural products. Facts and Comparisons, St. Louis 2000.</li><li class=\"breakAll\">Blumenthal M, Gruenwald J, Hall T, et al. German Commission E monographs: therapeutic monographs on medicinal plants, American Botanical Council, Austin 1998.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/6\" class=\"nounderline abstract_t\">Barrette EP. Use of saw palmetto extract for benign prostatic hyperplasia. Alternative Medicine Alert 1998; 1:1.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/7\" class=\"nounderline abstract_t\">Di Silverio F, Monti S, Sciarra A, et al. Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia. Prostate 1998; 37:77.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/8\" class=\"nounderline abstract_t\">Marks LS, Hess DL, Dorey FJ, et al. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens. Urology 2001; 57:999.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/9\" class=\"nounderline abstract_t\">Goepel M, Hecker U, Krege S, et al. Saw palmetto extracts potently and noncompetitively inhibit human alpha1-adrenoceptors in vitro. Prostate 1999; 38:208.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/10\" class=\"nounderline abstract_t\">Strauch G, Perles P, Vergult G, et al. Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers. Eur Urol 1994; 26:247.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/11\" class=\"nounderline abstract_t\">Wadsworth TL, Carroll JM, Mallinson RA, et al. Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells. Endocrinology 2004; 145:3205.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/12\" class=\"nounderline abstract_t\">Suzuki M, Oki T, Sugiyama T, et al. Muscarinic and alpha 1-adrenergic receptor binding characteristics of saw palmetto extract in rat lower urinary tract. Urology 2007; 69:1216.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/13\" class=\"nounderline abstract_t\">Levin RM, Das AK. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens. Urol Res 2000; 28:201.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/14\" class=\"nounderline abstract_t\">Paubert-Braquet M, Mencia Huerta JM, Cousse H, Braquet P. Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils. Prostaglandins Leukot Essent Fatty Acids 1997; 57:299.</a></li><li class=\"breakAll\">Dreikorn K, Richter R. Conservative nonhormonal treatment of patients with benign prostatic hyperplasia. In: New Developments in Biosciences 5, Prostatic Hyperplasia, Ackerman R, Schroeder FH (Eds), Walter de Gruyter and Co, Berlin 1989. p.109.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/16\" class=\"nounderline abstract_t\">Marwick C. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA 1995; 273:607.</a></li><li class=\"breakAll\">McGuire E. Detrusor response to obstruction. Department of Health and Human Services, Bethesda, MD 1987.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/18\" class=\"nounderline abstract_t\">Di Silverio F, D'Eramo G, Lubrano C, et al. Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur Urol 1992; 21:309.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/19\" class=\"nounderline abstract_t\">Veltri RW, Marks LS, Miller MC, et al. Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism. Urology 2002; 60:617.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/20\" class=\"nounderline abstract_t\">Tacklind J, Macdonald R, Rutks I, et al. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev 2012; 12:CD001423.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/21\" class=\"nounderline abstract_t\">Shoskes DA. Phytotherapy in chronic prostatitis. Urology 2002; 60:35.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/22\" class=\"nounderline abstract_t\">Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol 2004; 171:284.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/23\" class=\"nounderline abstract_t\">Boon H, Westlake K, Stewart M, et al. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology 2003; 62:849.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/24\" class=\"nounderline abstract_t\">Carraro JC, Raynaud JP, Koch G, et al. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate 1996; 29:231.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/25\" class=\"nounderline abstract_t\">Gerber GS, Zagaja GP, Bales GT, et al. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. Urology 1998; 51:1003.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/26\" class=\"nounderline abstract_t\">Braeckman J, et al. Efficacy and safety of the extract of Serenoa repens in the treatment of BPH: therapeutic equivalence between twice and once daily dosage forms. Phytotherapy Res 1997; 11:558.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/27\" class=\"nounderline abstract_t\">Braeckman J. The extract of Serenoa repens in the treatment of BPH: A multicenter open study. Curr Ther Res 1994; 55:776.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/28\" class=\"nounderline abstract_t\">Hamid S, Rojter S, Vierling J. Protracted cholestatic hepatitis after the use of prostata. Ann Intern Med 1997; 127:169.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/29\" class=\"nounderline abstract_t\">Wargo KA, Allman E, Ibrahim F. A possible case of saw palmetto-induced pancreatitis. South Med J 2010; 103:683.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/30\" class=\"nounderline abstract_t\">Jibrin I, Erinle A, Saidi A, Aliyu ZY. Saw palmetto-induced pancreatitis. South Med J 2006; 99:611.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/31\" class=\"nounderline abstract_t\">Cheema P, El-Mefty O, Jazieh AR. Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: a case report and review of literature. J Intern Med 2001; 250:167.</a></li><li class=\"breakAll\">Newall CA, Anderson LA, Phillipson JD. Herbal medicines: A guide for health-care professionals, The Pharmaceutical Press, London 1996.</li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/33\" class=\"nounderline abstract_t\">Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286:208.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/34\" class=\"nounderline abstract_t\">Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther 2004; 76:428.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/35\" class=\"nounderline abstract_t\">Markowitz JS, Donovan JL, Devane CL, et al. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin Pharmacol Ther 2003; 74:536.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/36\" class=\"nounderline abstract_t\">Feifer AH, Fleshner NE, Klotz L. Analytical accuracy and reliability of commonly used nutritional supplements in prostate disease. J Urol 2002; 168:150.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/37\" class=\"nounderline abstract_t\">Habib FK, Wyllie MG. Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract. Prostate Cancer Prostatic Dis 2004; 7:195.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-use-of-saw-palmetto/abstract/38\" class=\"nounderline abstract_t\">Scaglione F, Lucini V, Pannacci M, et al. Comparison of the potency of different brands of Serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells. Pharmacology 2008; 82:270.</a></li><li class=\"breakAll\">www.fda.gov/bbs/topcs/NEWS/2007/NEW01657.html (Accessed on October 09, 2007).</li></ol></div><div id=\"topicVersionRevision\">Topic 1388 Version 22.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H13\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">MECHANISM OF ACTION</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CLINICAL TRIALS/INDICATIONS</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Benign prostatic hypertrophy</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Prostatitis</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Prostate cancer</a></li></ul></li><li><a href=\"#H7\" id=\"outline-link-H7\">SAFETY</a><ul><li><a href=\"#H8\" id=\"outline-link-H8\">Adverse reactions</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Contraindications</a></li></ul></li><li><a href=\"#H10\" id=\"outline-link-H10\">HERB-DRUG INTERACTIONS</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">DOSE</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">BRAND</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PC/1388|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PC/57176\" class=\"graphic graphic_picture\">- Saw palmetto</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=alternative-endocrine-therapies-for-castration-resistant-prostate-cancer\" class=\"medical medical_review\">Alternative endocrine therapies for castration-resistant prostate cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-prostatitis-and-chronic-pelvic-pain-syndrome\" class=\"medical medical_review\">Chronic prostatitis and chronic pelvic pain syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=medical-treatment-of-benign-prostatic-hyperplasia\" class=\"medical medical_review\">Medical treatment of benign prostatic hyperplasia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-herbal-medicine-and-dietary-supplements\" class=\"medical medical_review\">Overview of herbal medicine and dietary supplements</a></li></ul></div></div>","javascript":null}